Anna

San Francisco, 22 Sep 2023: The Report Suture Needles Market Size, Share & Trends Analysis Report By Shape (Straight Shaped, J Shape), By Type (Tapercut, Conventional Cutting), By Application (Cardiovascular, Veterinary Procedures), By Region, And Segment Forecasts, 2021 - 2028 The global suture needles market size is expected to reach USD 740.9 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.2% from 2021 to 2028. An increasing incidence of chronic diseases and a rising number of surgical procedures are driving the market. In 2020, the COVID-19 pandemic stunted the market growth owing to the supply shortages of medical equipment because of temporary lockdowns of manufacturing sites in COVID-19-affected countries and travel restrictions affecting shipments. However, as the global economy returns to normal, the number of surgical procedures on hold will gradually increase, leading to market growth during the beginning of the first quarter of 2021. The market growth is projected to be restrained by an increase in the number of suture needle injuries. Many healthcare professionals, particularly in super-specialized hospitals and tertiary care centers, have begun to use surgical staplers for suturing, which may act as a further restraint and lower the demand for suture needles. Technological advancements such as endo-mechanical, suture, and curved needle technologies and advanced new laparoscopic suturing needles, combined with composite materials, have resulted in improved health outcomes, higher satisfaction, and surgical treatment timeliness. As a result, advanced technology is expected to drive the market forward. Access Research Report of Suture Needles Market @ https://www.grandviewresearch.com/industry-analysis/suture-needles-market-report Suture Needles Market Report Highlights By shape, the straight shaped needles segment held the largest revenue share in 2020 due to its easy accessibility during surgeries, along with its high flexibility, greater strength, and pliability as compared to other shapes Based on type, tapercut needles held the largest revenue share in 2020. The taper-point needle is used to puncture easily penetrated tissues (such as subcutaneous layers, abdominal viscera, peritoneum, and dura) while minimizing fascia tearing, which is anticipated to boost the demand for suture needles North America is expected to maintain its lead over the forecast period owing to technological advancements, an increase in patients opting for cosmetic procedures, and the high rate of adoption of minimally invasive treatments for cardiovascular diseases Suture Needles Market Report Scope Report Attribute Details Market size value in 2021 USD 494.6 million Revenue forecast in 2028 USD 740.9 million Growth Rate CAGR of 5.2% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of Suture Needles Market Medtronic Futura Surgicare Pvt. Ltd. Johnson & Johnson Medical N.V. Aurolab Natsume Seisakusho Co., Ltd. Alfresa Pharma Corporation Bear Medic Corporation SUTUREX & RENODEX Teleflex Incorporated Smith & Nephew Hu-Friedy Mfg. Co., LLC FSSB Chirurgische Nadeln GmbH Burtons Medical Equipment Ltd. Advin Health Care Access Press Release of Suture Needles Market @ https://www.grandviewresearch.com/press-release/global-suture-needles-market  

San Francisco, 21 Sep 2023: The Report Hospital Consumables Market Size, Share & Trends Analysis Report By Product (Non-woven Disposable Products, Disposable Medical Gloves), By Region (North America, APAC), And Segment Forecasts, 2021 - 2028 The global hospital consumables market is expected to reach USD 713.1 billion by 2028, registering a CAGR of 10.89% over the forecast period, according to a new report by Grand View Research, Inc. Hospitals, private medical practices, and patients, especially in developed nations, are gradually shifting towards utilization of disposable hospital consumables due to convenience and safety offered by these products. Therefore, the product demand is rapidly increasing across the globe, thereby driving market growth. Moreover, the increasing prevalence of Hospital-Acquired Infections (HAIs) is creating high product demand in hospitals as well as other healthcare settings. For instance, out of every 100 hospitalized patients, 7 in developed and 10 in developing countries are affected with at least one Healthcare-associated Infections (HCAIs). Several measures, including the usage of disposable & sterile products, disposable gloves, medical gauze, tapes, procedure kits & trays, and other disposable hospital consumables, are now being utilized to prevent and reduce the prevalence of HAIs. Moreover, expanding infrastructure and rising demand for maintenance & hygiene in healthcare institutes are further boosting the market growth. Many hospitals and health care centers are considerably focusing on upgrading the quality of infrastructure, maintaining hygiene, and efficacy of operational systems, which will have a positive impact on the market growth. In addition, a large population base in developed countries, such as the U.S., is able to spend and afford better-quality healthcare. According to CMS.gov, the U.S. healthcare expenditure grew 4.6% in 2019, reaching USD 3.8 trillion or USD 11,582 per person, accounting for 17.7% of the nation’s GDP. Thus, increasing healthcare expenditure is also one of the key factors stimulating market growth. Access Research Report of Hospital Consumables Market @ https://www.grandviewresearch.com/industry-analysis/hospital-consumables-market-report Hospital Consumables Market Report Highlights The non-woven disposable products segment held the largest revenue share in 2020 and will expand at a steady CAGR over the forecast years retaining the leading market position This growth is credited to the high prevalence of HAIs and subsequently rising hospital admissions for surgeries The market in the Asia Pacific region is expected to register the fastest CAGR from 2021 to 2028 This growth is owing to the increasing population coupled with the rapid expansion of the medical tourism sector in the region Key players focus more on business strategies, such as mergers & acquisitions, partnerships, and new product launches, to strengthen their foothold in the global market Hospital Consumables Market Report Scope Report Attribute Details Market size value in 2021 USD 345.99 billion Revenue forecast in 2028 USD 713.17 billion Growth rate CAGR of 10.89% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of Hospital Consumables Market McKesson Medical-Surgical Inc. Medline Industries, Inc. Braun Melsungen A.G. Terumo Medical Corporation Owens and Minor Smith And Nephew, Inc. Cardinal Health 3M Baxter Fresenius Medical Care AG & Co. KGaA Access Press Release of Hospital Consumables Market @ https://www.grandviewresearch.com/press-release/global-hospital-consumables-market  

San Francisco, 21 Sep 2023: The Report Drainage Bottles Market Size, Share & Trends Analysis Report By Application (Accel Evacuated, Urostomy/Urinary), By End Use (Hospitals & Clinics, Homecare, Nursing Facilities), By Region, And Segment Forecasts, 2021 - 2028 The global drainage bottles market size is anticipated to reach USD 704.3 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.0% from 2021 to 2028. Increasing incidence of accidents, increasing prevalence of diseases such as uremia and cardiovascular disease, and rising number of thoracic surgeries are driving the market. Drainage bottles are used in surgeries such as thoracic surgery, and in the treatment of wounds. Thus, the increasing prevalence of wounds and rising number of accidents are a few factors increasing the demand for drainage bottles. For instance, as per the National Health Portal, in India, approximately 7 million people suffer from a type of burn injury every year. In addition, as per CDC, every year approximately 1.35 million people are killed in road accidents across the globe. Furthermore, around 20-50 million people suffer non-fatal injuries resulting in long-term disabilities. During the COVID-19 pandemic, the demand for drainage bottles has increased due to the increased number of hospital admissions of people suffering from COVID-19. The increasing prevalence of COVID has also resulted in other diseases such as pneumonia, which do require chest drainage for treatment, thus, increasing the demand for drainage bottles. Access Research Report of Drainage Bottles Market @ https://www.grandviewresearch.com/industry-analysis/drainage-bottles-market-report Drainage Bottles Market Report Highlights On the basis of application, the chest drainage segment dominated the market with a share of 26.0% in 2020, owing to the high adoption of drainage bottles during cardiovascular procedures and outbreak of COVID-19 Based on end use, the hospitals & clinics segment dominated the market with a share of 63.0% in 2020. The segment growth is majorly driven by the increasing number of patients suffering from cardiovascular disorders Asia Pacific dominated the market with the highest revenue share of 30.07% in 2020, owing to the presence of a large patient pool along with the rising aging population Drainage Bottles Market Report Scope Report Attribute Details Market size value in 2021 USD 467.2 million Revenue forecast in 2028 USD 704.3 million Growth Rate CAGR of 6.0% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of Drainage Bottles Market PAHSCO PFM Medical, Inc. Lily Medical Corporation Hospitech MEDINORM Medizintechnik GmbH Jigsaw Medical, LLC Braun Medical Inc. Sterimed Group Rocket Medical plc Access Press Release of Drainage Bottles Market @ https://www.grandviewresearch.com/press-release/global-drainage-bottles-market  

San Francisco, 20 Sep 2023: The Report Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges, Sublingual Films), By Application, By End-user, By Region, And Segment Forecasts, 2021 - 2028 The global buccal drug delivery systems market size is expected to reach USD 5.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing. Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022. Access Research Report of Buccal Drug Delivery Systems Market @ https://www.grandviewresearch.com/industry-analysis/buccal-drug-delivery-systems-market -report Buccal Drug Delivery Systems Market Report Highlights The buccal tablets and lozenges type segment accounted for the largest revenue share in 2020 due to its wider acceptance among patients The smoking cessation application segment held the largest share in 2020. Buccal drug delivery is often the most preferred and effective formulation for treating patients with smoking or nicotine addiction The hospital end-user segment captured the largest revenue share in 2020 owing to a large number of admissions of geriatric patients and abundant medication supplies North America held the largest revenue share in 2020 due to a large number of leading manufacturers and growing research in the region Buccal Drug Delivery Systems Market Report Scope Report Attribute Details Market size value in 2021 USD 3.2 billion Revenue forecast in 2028 USD 5.9 billion Growth Rate CAGR of 9.2% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of Buccal Drug Delivery Systems Market Teva Pharmaceutical Industries Ltd. Pfizer Inc. GlaxoSmithKline plc. Indivior Pharmaceuticals Generex Biotechnology Catalent ARx LLC BioDelivery Sciences International, Inc. Cynapsus Therapeutics Inc.  Endo Pharmaceuticals plc Access Press Release of Buccal Drug Delivery Systems Market @ https://www.grandviewresearch.com/press-release/global-buccal-drug-delivery-systems-market  

San Francisco, 20 Sep 2023: The Report Rat And Mouse Model Market Size, Share & Trends Analysis Report By Type (Knockout, Knock-in), By Technology, By Service (Breeding, Rederivation), By Application (COVID-19, CVS), By End-use, And Segment Forecasts, 2021 - 2028 The global rat and mouse model market size is anticipated to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. Recent advancements in the field of genetic engineering including piggyBac technologies, Cas-CLOVER, and CRISPR/Cas9 facilitate researchers to develop immunodeficient rat models which can be used for human cell/tissue regeneration and transplants. Key companies have leveraged advanced technologies such as machine learning, big data analytics, genome engineering tools, and next-generation sequencing technology to develop mouse and rat models with more human-like microbiomes, immune systems, and genetic backgrounds. For instance, models from the Jackson Laboratory reflect the genetic diversity showcased by the human population. Market participants are focused to develop novel methods to certify that in vivo and in vitro testing complement each other. In this regard, an increase in the adoption rate of organoid systems has been observed. These systems guide engineering as well as enhance the use and selection of animal models. Moreover, the rise in utilization of mouse model in the analysis of SARS-CoV-2 infection in upper and lower respiratory tract infections drives the global market. Access Research Report of Rat And Mouse Model Market @ https://www.grandviewresearch.com/industry-analysis/rat-mouse-model-market-report Rat And Mouse Model Market Report Highlights The outbred model system generated the largest revenue amongst model type as outbred strains are genetically diverse and feature well-characterized, stable genetic variation which accurately reflects the genetic structure of human populations Therefore, outbred strains such as the Diversity Outbred (DO) mice are used to analyze the genetic complexity behind cancer, autoimmune disorders, addiction, obesity, heart disease, diabetes, and Alzheimer's disease The CRISPR/Cas9 segment is anticipated to witness the fastest CAGR from 2021 to 2028 as CRISPR/Cas9 can target any definite exons for exclusion or inclusion within an mRNA Additionally, the use of the CRISPR/Cas9 system to generate the knockout mouse models simplifies the whole process and reduces the timeframe from 1-2 years to 6 months The cryopreservation segment is expected to gain significant traction during the forecast period The technique provides a fast and reliable procedure for archiving sperm and embryos of valuable mice strains Cancer is the largest revenue-generating application segment as the mouse and human genomes are homologous. Thus, it provides a good tool for cancer research as well as for drug discovery Pharmaceutical and biotechnology companies dominated the end-use segment in terms of revenue share in 2020. Rat and mice models are some of the most used animal models in drug discovery Techniques such as CRISPR/Cas9, homologous recombination, and random transgenesis help the biotech and pharma companies to analyze hypotheses or to generate rat models for human diseases Genetically engineered models play a vital role to assess and characterize target identification, disease pathology, and in vivo assessment of new molecular entities Profitable opportunities offered by the developing nations and have attracted investments from global companies in the Asia Pacific region For instance, in July 2021, ERS Genomics Limited signed a non-exclusive license agreement with Japan SLC. This provided the latter access to CRISPR/Cas9 patent portfolio offered by ERS Genomics As Japan SLC offers transgenic, hybrid, congenic, immunodeficient, inbred, and outbred animal models to research organizations; an addition of CRISPR/Cas9 technology will enhance its portfolio for rat and mouse models in Japan Rat And Mouse Model Market Report Scope Report Attribute Details Market size value in 2021 USD 2.03 billion Revenue forecast in 2028 USD 2.93 billion Growth Rate CAGR of 5.5% from 2021 to 2028 Base year for estimation 2020 Historical data 2018 - 2019 Forecast period 2021 - 2028 List of Key Players of Rat And Mouse Model Market Charles River Laboratories International, Inc. The Jackson Laboratory Laboratory Corporation of America Holdings (Covance) Perkin Elmer (Horizon Discovery Group plc) genOway Envigo JANVIER LABS Taconic Biosciences, Inc. Biomedical Research Models (Biomere) Transpogen Biopharmaceutical, Inc. Access Press Release of Rat And Mouse Model Market @ https://www.grandviewresearch.com/press-release/global-rat-mouse-model-market  

San Francisco, 20 Sep 2023: The Report Automated Suturing Devices Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Cardiac, Orthopedic, Gastrointestinal, Ophthalmic), By End Use, By Region, And Segment Forecasts, 2021 - 2028 The global automated suturing devices market size is expected to reach USD 5.1 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2021 to 2028. The factors influencing market growth include the increasing prevalence of chronic disorders, the growing geriatric population, rising preference of minimally invasive surgeries over traditional methods, growing technological advancements, and novel innovations in surgical equipment is also propelling the growth. However, lower penetration of automated suturing devices in developing economies and a lack of skilled professionals are expected to hinder market growth. The increasing prevalence of minimally invasive surgeries for the preventive treatment of chronic disorders such as cardiac, orthopedic, gastrointestinal, and gynecological surgeries is expected to fuel market growth. Minimally invasive surgeries have advantages such as safety, shorter hospital stay and recovery time, and an overall reduction in hospital bills. These minimally invasive surgeries are economically viable alternatives to open or traditional surgeries. Technological advancements in minimally invasive surgeries and the introduction of new products in the market are among factors expected to drive the market. Furthermore, the increasing geriatric population leads to a heavy financial burden on the global healthcare system. According to Population Reference Bureau, in the U.S., the number of people aged 65 years and above is expected to reach 95 million by 2060. Such a sudden increase in geriatrics is expected to increase the demand for automated suturing devices for preventive surgeries and which in turn, fuels market growth. Increasing number of initiatives being undertaken by governments and nonprofit organizations to increase awareness about minimally invasive surgeries is expected to boost the adoption of automated suturing devices used for preventive treatment. Access Research Report of Automated Suturing Devices Market @ https://www.grandviewresearch.com/industry-analysis/automated-suturing-devices-market-report Automated Suturing Devices Market Report Highlights The reusable automated suturing devices segment has captured the largest revenue share in 2020 The cardiac segment dominated the market and accounted for revenue share in 2020 followed by the orthopedic segment in 2020 owing to the rising burden of cardiovascular disorders is the major factor contributing to segment growth The ASC segment is predicted to witness the fastest growth rate over the forecast timeframe due to increasing patient footfall and quick turnaround North America dominated the market and is predicted to maintain its dominance over the forecast period Automated Suturing Devices Market Report Scope Report Attribute Details Market size value in 2021 USD 3.2 billion Revenue forecast in 2028 USD 5.1 billion Growth Rate CAGR of 6.7% from 2021 to 2028 Base year for estimation 2020 Historical data 2017 - 2019 Forecast period 2021 - 2028 List of Key Players of Automated Suturing Devices Market Medtronic Plc Boston Scientific BD EndoEvolution LSI Solutions, Inc. Smith & Nephew Sutrue Apollo Endo-surgery Access Press Release of Automated Suturing Devices Market @ https://www.grandviewresearch.com/press-release/global-automated-suturing-devices-market  

San Francisco, 20 Sep 2023: The Report Pulse Electromagnetic Field Therapy Devices Market Size, Share & Trends Analysis Report By Application (Bone Growth, Pain Relief), By Power (Low Frequency, High Frequency), By End-use, And Segment Forecasts, 2021 - 2028 The global pulse electromagnetic field therapy devices market is expected to reach USD 693.3 million by 2028, registering a CAGR of 7.8% over the forecast period, according to a new report by Grand View Research, Inc. Increasing focus on the development of advanced products is expected to boost the market growth. Furthermore, increasing cases of sports injuries and road accidents are expected to boost the demand for these devices, thereby augmenting the market growth. For instance, according to the WHO, about 1.3 million people die every year due to road traffic crashes. Strict lockdown restrictions have been put in place across various regions to limit the spread of the COVID-19 disease. With travel restrictions, quarantine as well as complete lockdowns in several countries, the economy has been slackened down and is moving into a state of recession. This has also included the healthcare systems across the globe. Furthermore, the COVID-19 pandemic affected traumatology and orthopedics, wherein nonurgent consultations were canceled and elective surgeries were postponed to reduce the risk of infection for medical staff as well as patients. Hence, the pandemic created a negative impact on the market growth. The U.S. FDA has approved pulse electromagnetic fields (PEMFs) as an effective and safe treatment for nonunion of bone. After the FDA approval, the product usage for bone repair has increased in Europe as well as in the U.S., fostering the overall market growth. Also, numerous studies have reported that the efficacy of these devices in treating nonunion fractures, with the healing rate, ranges from 68% to 90%. Earlier in vivo and in vitro studies demonstrated that the application of PEMF therapy increased the expression of growth factors and improved the local environment to facilitate the bone healing process. Access Research Report of Pulse Electromagnetic Field Therapy Devices Market @ https://www.grandviewresearch.com/industry-analysis/pulse-electromagnetic-field-pemf-therapy-devices-market-report Pulse Electromagnetic Field Therapy Devices Market Report Highlights The low-frequency power segment accounted for the largest revenue share in 2020 as these devices are shown to be nonionizing and nonthermal The pain relief application segment accounted for the highest revenue share in 2020 owing to the increasing cases of pain-related disorders The hospitals end-use segment dominated the global PEMF therapy devices market in 2020 and is estimated to expand further at the fastest CAGR from 2021 to 2028 The home care settings segment is expected to experience the fastest growth rate throughout the forecast period owing to the increasing popularity of PEMF therapy devices along with increasing social media influence Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period due to the rising cases of sports injuries and fractures Pulse Electromagnetic Field Therapy Devices Market Report Scope Report Attribute Details Market size value in 2021 USD 409.5 million Revenue forecast in 2028 USD 693.3 million Growth rate CAGR of 7.8% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of Pulse Electromagnetic Field Therapy Devices Market Bedfont Scientific Orthofix Holdings I-Tech Medical Division OSKA Medithera NiuDeSai Nuage Health Oxford Medical Instruments Health Bemer, LLC Access Press Release of Pulse Electromagnetic Field Therapy Devices Market @ https://www.grandviewresearch.com/press-release/global-pulse-electromagnetic-field-pemf-therapy-devices-market  

San Francisco, 18 Sep 2023: The Report Weight Loss Supplements Market Size, Share & Trends Analysis Report By End User (18-40 Years, Under 18 Years), By Distribution Channel (Offline, Online), By Type (Powders, Pills), By Ingredient, And Segment Forecasts, 2021 - 2028 The global weight loss supplements market size is expected to reach USD 116.6 billion by 2028, registering a CAGR of 16.6% over the forecast period, according to a new report by Grand View Research, Inc. Rising cases of obesity across the globe coupled with increasing consumer awareness levels about following a healthier and fit lifestyle will drive the market. In addition, a rising number of fitness centers and gyms in several countries and increased awareness about the importance of weight loss supplements are projected to drive the market growth. Moreover, rising disposable income levels and improved accessibility & affordability of surgeries are propelling the market growth. The growing number of bariatric surgeries across the globe per year is expected to positively contribute to the growth of the market. As per the American Society for Metabolic and Bariatric Surgeries (ASMBS) estimates in 2017, approximately 228,000 individuals underwent a weight loss surgery in the U.S. whereas, 580,000 patients globally undergo bariatric surgeries every year. Furthermore, individuals are actively participating in fitness activities and signing up for gyms & wellness centers’ memberships. The growing awareness levels about obesity-related health ailments are expected to drive product consumption. As per the International Health, Racquet & Sportsclub Association (IHRSA) estimates, there has been a 27% rise in the number of health club members, from 58 million in 2010 to 73.6 million in 2019. The number of health clubs in the U.S. also increased by 5.2%, from 36,540 in 2016 to 38,447 in 2017. The powder type segment dominated the market in 2020 with the growing need to curb obesity and prevent obesity-related health ailments. The vitamins & minerals segment dominated the market owing to the rise in health consciousness and increased number of fitness centers & gyms across various countries. The age group of 18-40 years old dominated the market due to the rising healthcare expenditure and reversal of sedentary lifestyles. Asia Pacific dominated the global market due to the growing prevalence of obesity in developing countries and rising expenses of bariatric surgeries. Access Research Report of Weight Loss Supplements Market @ https://www.grandviewresearch.com/industry-analysis/weight-loss-supplements-market-report Weight Loss Supplements Market Report Highlights The global market size is anticipated to be valued at USD 116.6 billion by 2028 due to the growing cases of obesity across the globe Based on type, the powder segment dominated the market due to higher bioavailability and regulated dosage of powders to support weight control and physical activity The vitamins & minerals ingredient segment led the market due to rising awareness regarding the health benefits associated with these supplements In the end-user segment, the age group of 18-40 years old dominated the market due to growing health consciousness Offline was the largest distribution channel segment in 2020 due to the high consumer base for retail pharmacies and department stores Weight Loss Supplements Market Report Scope Report Attribute Details Market size value in 2021 USD 39.8 billion Revenue forecast in 2028 USD 116.6 billion Growth rate CAGR of 16.6% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of Weight Loss Supplements Market Glanbia PLC GlaxoSmithKline PLC Herbalife Nutrition Ltd. Abbott Kellogg Company Nestle Kraft Heinz Company Amway Corp. PepsiCo Ajinomoto Co. Inc. Access Press Release of Weight Loss Supplements Market @ https://www.grandviewresearch.com/press-release/global-weight-loss-supplements-market  

San Francisco, 18 Sep 2023: The Report North America Unit Dose Manufacturing Market Size, Share & Trends Analysis Report By Source (In-house, Outsourcing), By Product, By End Use (Independent Pharmacies, Long Term Care Facility), By Country, And Segment Forecasts, 2021 - 2028 The North America unit dose manufacturing market size is expected to reach USD 21.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 16.9% from 2021 to 2028. The rapidly growing pharmaceutical industry and rising demand for unit doses are factors driving the market. Single-dose packaging has certainly become one of the most popular recent trends. The most obvious benefit is its ease of use and improved medication management, as they can be prescribed by the unit, ensuring that the person taking it does not exceed the prescribed dose. Stick packs are unique in the way that they can be used to package a variety of items, both dry and wet. Measuring cups, teaspoons, tablespoons, and multi-dose containers for oral liquids and eye drops have been already seen. The current patient is seeking convenience. Doctors are also appreciating the importance of unit dose in prescription writing since it allows them to prescribe controlled substance oral liquid without concern of abuse as unit doses address the issue. It also enables pharmacists to store oral liquids in a secure manner, which is a significant additional benefit. Nearly every single unit dose oral solid or multiple-dose oral liquid could be transformed to a unit dose oral liquid due to this innovation. However, owing to the COVID-19 pandemic's repercussions, the unit dose manufacturing market increased at a modest 11.0% year over year in 2020. By the end of 2020, the market started to recover. COVID-19-related illnesses are being treated using unit dosages. Hospitals have updated and implemented various new standard operating procedures to protect both patients and healthcare workers. As a consequence, it's crucial to consider out viral transmission by airborne transmission or direct contact. When unit dose medicines are used, some of the risks involved with handling and pouring doses from the same bottle are reduced.  Access Research Report of North America Unit Dose Manufacturing Market @ https://www.grandviewresearch.com/industry-analysis/north-america-unit-dose-manufacturing-market-report North America Unit Dose Manufacturing Market Report Highlights The outsourcing segment dominated the market and accounted for the largest revenue share of 59.6% in 2020. Unit doses lead to the minimization of credits for drugs coupled with greater control by a pharmacist over work patterns and schedules The solid unit dose segment held 49.1% of the revenue share in 2020. In 2018, oral solid dosage medicines accounted for 53% of all new pharmaceuticals approved by the FDA The independent pharmacies segment dominated the market and accounted for the largest revenue share of 34.1% in 2020 The hospital segment held the second-largest revenue share in 2020. The segment is estimated to become 3.5 times of itself by 2028 North America Unit Dose Manufacturing Market Report Scope Report Attribute Details Market Size value in 2021 USD 7.2 billion Revenue forecast in 2028 USD 21.7 billion Growth Rate CAGR of 16.9% from 2021 to 2028 Base year for estimation 2020 Historical data 2016 - 2019 Forecast period 2021 - 2028 List of Key Players of North America Unit Dose Manufacturing Market Catalent Thermo Fisher Pantheon Unither Pharmaceuticals Mikart TapeMark Renaissance Lakewood LLC Medical Packaging Inc. CordenPharma American Health Packaging Access Press Release of North America Unit Dose Manufacturing Market @ https://www.grandviewresearch.com/press-release/north-america-unit-dose-manufacturing-market-analysis